about
Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profilingPioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisLiver injury from tumor necrosis factor-α antagonists: analysis of thirty-four casesHost Genetics, Steatosis and Insulin Resistance among African Americans and Caucasian Americans with Hepatitis C Virus Genotype-1 InfectionNIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportEndemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndromeImmune dysregulation in human subjects with heterozygous germline mutations in CTLA4Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseEarly-onset stroke and vasculopathy associated with mutations in ADA2Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.A spectrum of severe familial liver disorders associate with telomerase mutations.A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous diseaseAccurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.Nodular regenerative hyperplasia in common variable immunodeficiency.Factors associated with the platelet count in patients with chronic hepatitis C.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Increased caffeine consumption is associated with reduced hepatic fibrosisEndpoints and clinical trial design for nonalcoholic steatohepatitis.Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.To resect or not to resect? That is the question. Telangiectatic adenoma.GI involvement in disseminated Mycobacterium genavense: endoscopy and histology.Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection.Long-term therapy of chronic delta hepatitis with peginterferon alfa.Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury networkMalignant insulinoma: spectrum of unusual clinical features.Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) studyViral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathyPortal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research networkPioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver diseaseRate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C TrialLong-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
P50
Q21133890-AE0E1FE9-3CBB-4E0F-8BB2-62A9765971D7Q24625697-77F4DBA0-10AE-4715-ACEC-31F2F900EF89Q26864098-98F97B8E-B0D8-4A8A-BA2D-D3F0949B86A4Q27490790-4F300A93-12B4-4DB0-BEBF-602357F88156Q28081289-2A58B96E-9C3F-4A64-9D94-469CF6D87C45Q28084749-21873ABE-95C2-4F2E-ADC3-658B2A33CD22Q28247732-917DF314-35B2-4519-A6FF-D6FF4D5FF3EAQ29614930-AD1EC753-985B-4053-8E39-B4101929AFEEQ30410263-04575E67-FE1D-494E-8857-A712EB60854AQ30434625-671EE749-985D-433F-A77A-C66FD731C5D4Q30447260-1373B46E-EAEA-491E-9314-00722E3AD82FQ30913791-7E397FBB-9A22-4569-98E0-3F2DA8BD8FF4Q31036756-9B140DDA-FC13-41F0-B5B4-94C72F4D14F9Q33244809-287C7F7C-6EDF-4E9F-8DE7-E3F301E01B47Q33379412-6BD2DED7-D7C9-4B0E-A96E-CF2F934163BAQ33405963-042A75F0-2B50-4AE5-BF31-B80721FA1C0AQ33420784-8871C7F7-51C8-45D8-B67D-9C85A16919CDQ33563333-C1CB5190-6784-42FC-B9E7-1BE4AF36D7E0Q33572385-0160655D-BBEE-4ED9-ACD0-9892E1A0767AQ33583798-56EF4C0A-F992-4E67-B9D2-0F8F131B619AQ33588960-46761CA2-C529-4169-9691-E902B83AC053Q33724754-0ECF6410-17BF-4BCE-8018-DCCBB08B343BQ33756657-EF466B40-DDD2-4BFD-9905-54FBDC7C7445Q33804116-97A6404B-1278-4103-99CC-D47971ADAB76Q33875928-7031A751-E4E1-46E7-95C4-1390B59BA1F7Q33889225-4739629E-047C-48AB-8311-79523AA9A690Q33904679-EC8FCBDC-E518-44A3-B68F-16D30DB955A3Q33946592-9438FE6D-2225-4A60-86DC-B44C7D10C187Q34061054-1BBF5E1C-4C6E-4CE8-B91E-F68F8564DEF0Q34072855-0C4F9F73-0043-4ACB-BE22-73CE2545921FQ34079748-D585CA9C-DD00-45AE-9D8F-A1CA7FF45F23Q34084853-20B20B4E-A85B-4DE9-BB31-F6FFDE252DFAQ34085058-0765A58B-4FBE-4669-A71F-EFCDB803FA79Q34090872-C734152B-84DE-4991-AC7B-7007F8B5CCE0Q34101263-C0C0C3B6-31D6-48D2-A462-FC3055641E13Q34194979-6E65523B-06F5-4547-BA4E-FBB3E615CF14Q34278369-33D328BA-8B78-4ACA-8B65-63A7375BAD8DQ34302040-F4CF4DA4-F1AA-4B41-9037-AE5920CC434BQ34344465-681DEE36-7E22-43CC-8923-816F9E0209D2Q34543902-D47F4653-98DE-4AA2-BC77-EFA664F6BFF6
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David E. Kleiner
@ast
David E. Kleiner
@en
David E. Kleiner
@es
David E. Kleiner
@sl
type
label
David E. Kleiner
@ast
David E. Kleiner
@en
David E. Kleiner
@es
David E. Kleiner
@sl
prefLabel
David E. Kleiner
@ast
David E. Kleiner
@en
David E. Kleiner
@es
David E. Kleiner
@sl
P1053
N-2770-2013
P106
P1153
7004569556
P21
P31
P3829
P496
0000-0003-3442-4453